Year: 2026
Type: preprint
Abstract: In response to the COVID-19 pandemic, local SARS-CoV-2 nanopore sequencing capacity was established at Irrua Specialist Teaching Hospital (ISTH), a Lassa fever reference centre based in Edo State, Nigeria. This was enabled through training of local staff in Nigeria and Guinea in both laboratory and bioinformatic SARS-CoV-2 sequencing protocols. Between March 2020 and December 2023, the laboratory at ISTH conducted 29,643 diagnostic tests for SARS-CoV-2, of which 4,575 (15.4%) were positive. Between April and December 2022, 410 SARS-CoV-2 positive samples were selected and retrospectively sequenced in 19 runs. From these, 213 near-complete (> 93%) viral genomes were generated and submitted to GISAID. Phylogenetic and phylogeographic analyses supported that Nigeria served simultaneously as a source and recipient of SARS-CoV-2 lineages, driving global spread of the AY.36 Delta variant and receiving Omicron sublineages (BA.1.1 and BQ.1) from North America and Europe. Here we show that a pre-existing long-term laboratory capacity development program for Lassa virus, a high-risk pathogen, facilitated the successful integration of novel workflows for a new emerging pathogen.
Source: Research Square
Authors: Cyril Erameh, Ehizojie Ehiremen Emua, Emanuele Gustani-Buss, Joseph Okoeguale, Alexandru Tomazatos, Racheal Omiunu, Sarah Ryter, Precious Olachukwu Njigha, Ganiyu Igenegbale, Obehiaghe Benedicta Okogbenin, Paulson Ehichioya Ebhodaghe, Kékoura Ifono, Emily Victoria Nelson, Mette Hinrichs, Julia Hinzmann, Christine Jacobsen, Beate Becker-Ziaja, Annick Renevey, N’Faly Magassouba, Sanaba Boumbaly, Jacob Camara, Fara Raymond Koundouno, Meike Pahlmann, Lisa Oestereich, Ikponmwosa Odia, Donatus Itsoghiaonode Adomeh, Ephraim Ogbaini-Emovon, Stephan Günther, Reuben Agbons Eifediyi, Liana Eleni Kafetzopoulou, Giuditta Annibaldis, Sylvanus Okogbenin, Sophie Duraffour
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7226034849
